Konstantinides S, Hasenfuss G
Abteilung Kardiologie und Pneumologie, Klinikum der Georg-August-Universität Göttingen.
Internist (Berl). 2004 Oct;45(10):1155-62. doi: 10.1007/s00108-004-1267-7.
Venous thromboembolism remains one of the most frequent and threatening acute cardiovascular syndromes. Its incidence has remained constant over the last several years, both in Europe and the United States, accounting for approximately 1.5 cases per 1000 inhabitants per year. Every year about 100 cases of venous thromboembolism per 100,000 inhabitants are admitted to the hospital, and 10% of these patients die during the hospital stay. Particularly alarming is the fact that in 50-70% of all patients who die from an acute pulmonary embolism the diagnosis is only made after death. These facts emphasize not only the relevance of the problem of "acute pulmonary embolism," but also the need for optimization of current diagnostic and therapeutic strategies. Rapid identification of acute cor pulmonale with echocardiography and cardiac biomarkers has recently proven to be especially helpful in this regard.
静脉血栓栓塞仍然是最常见且危险的急性心血管综合征之一。在过去几年中，其发病率在欧洲和美国一直保持稳定，每年每1000名居民中约有1.5例发病。每年每10万居民中约有100例静脉血栓栓塞患者住院，其中10%的患者在住院期间死亡。特别令人担忧的是，在所有死于急性肺栓塞的患者中，有50%-70%是在死后才做出诊断。这些事实不仅强调了“急性肺栓塞”问题的重要性，也凸显了优化当前诊断和治疗策略的必要性。最近已证明，通过超声心动图和心脏生物标志物快速识别急性肺心病在这方面特别有帮助。
